This inventor holds 1 USPTO granted patent. Top assignee: Gambro Lundia Ab. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Célina Granolleras: Innovator in Blood Treatment Procedures
Introduction
Célina Granolleras is a notable inventor based in Montpellier, France. He has made significant contributions to the field of blood treatment procedures, particularly through his innovative patent. His work focuses on improving the efficiency and effectiveness of dialysis treatments.
Latest Patents
Célina Granolleras holds a patent for a "Method and system for preventing intradialytic symptomatology." This patent outlines methods and apparatus for conducting blood treatment procedures. The method includes conducting the treatment procedure, such as dialysis, at a first efficiency until a limit value is reached. Subsequently, the efficiency is altered to a second efficiency until a second limit value is reached. Additionally, the method involves devising a predetermined efficiency profile for the blood treatment procedure, conducting the procedure at a predetermined efficiency until a first limit value is reached, and then adjusting the efficiency in accordance with the predetermined efficiency profile.
Career Highlights
Célina Granolleras is associated with Gambro Lundia AB, a company known for its advancements in medical technology and blood treatment solutions. His work at the company has been instrumental in developing innovative approaches to dialysis and improving patient outcomes.
Collaborations
Célina collaborates with Stanley Shaldon, a fellow expert in the field. Their partnership has contributed to the advancement of techniques and methodologies in blood treatment.
Conclusion
Célina Granolleras is a pioneering inventor whose work in blood treatment procedures has the potential to enhance the quality of care for patients undergoing dialysis. His innovative methods and collaboration with industry experts underscore his commitment to improving medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
